Zoetis Inc. (ZTS)

↓ Download CSV

CIK 0001555280 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

In fiscal 2025, Zoetis Inc. reported revenue of $9.47B, up 2.3% from the prior year. The company was profitable, with a net margin of 28.2%. It held $15.47B in total assets against $12.14B in total liabilities.

Key ratios (FY2025)

28.2%
Net margin
80.2%
Return on equity
+2.3%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$9.47B$9.26B$8.54B$8.08B$7.78B$6.67B$6.26B$5.83B$5.31B$4.89B
Cost of Revenue$2.67B$2.72B$2.56B$2.45B$2.30B$2.06B$1.99B$1.91B$1.77B$1.67B
Net Income$2.67B$2.49B$2.34B$2.11B$2.04B$1.64B$1.50B$1.43B$864.00M$821.00M
EPS (Diluted)$6.02$5.47$5.07$4.49$4.27$3.42$3.11$2.93$1.75$1.65
Total Assets$15.47B$14.24B$14.29B$14.93B$13.90B$13.61B$11.54B$10.78B$8.59B$7.65B
Total Liabilities$12.14B$9.47B$9.29B$10.52B$9.36B$9.84B$8.84B$8.59B$6.80B$6.15B
Shareholders' Equity$3.33B$4.77B$4.99B$4.40B$4.54B$3.77B$2.71B$2.19B$1.79B$1.50B
Cash & Equivalents$1.56B$727.00M
Operating Cash Flow$2.90B$2.95B$2.35B$1.91B$2.21B$2.13B$1.79B$1.79B$1.35B$713.00M
Capital Expenditures$621.00M$655.00M$732.00M$586.00M$477.00M$453.00M$460.00M$338.00M$224.00M$216.00M
Shares Outstanding443.83M454.85M462.27M470.38M476.72M478.57M481.79M486.90M493.16M498.23M
Dividends Per Share$2.03$1.80$1.56$1.35$1.07$0.85$0.69$0.54$0.44$0.39